BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31306793)

  • 1. Unconventional diagnostic tests for Lyme borreliosis: a systematic review.
    Raffetin A; Saunier A; Bouiller K; Caraux-Paz P; Eldin C; Gallien S; Jouenne R; Belkacem A; Salomon J; Patey O; Talagrand-Reboul E; Jaulhac B; Grillon A
    Clin Microbiol Infect; 2020 Jan; 26(1):51-59. PubMed ID: 31306793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological diagnostics of Lyme borreliosis: comparison of assays in twelve clinical laboratories in Northern Europe.
    Lager M; Dessau RB; Wilhelmsson P; Nyman D; Jensen GF; Matussek A; Lindgren PE; Henningsson AJ; ; Baqir H; Serrander L; Johansson M; Tjernberg I; Skarstein I; Ulvestad E; Grude N; Pedersen AB; Bredberg A; Veflingstad R; Wass L; Aleke J; Nordberg M; Nyberg C; Perander L; Bojesson C; Sjöberg E; Lorentzen ÅR; Eikeland R; Noraas S; Henriksson GA; Petrányi G
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1933-1945. PubMed ID: 31399914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis.
    Dessau RB; van Dam AP; Fingerle V; Gray J; Hovius JW; Hunfeld KP; Jaulhac B; Kahl O; Kristoferitsch W; Lindgren PE; Markowicz M; Mavin S; Ornstein K; Rupprecht T; Stanek G; Strle F
    Clin Microbiol Infect; 2018 Feb; 24(2):118-124. PubMed ID: 28887186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.
    Leeflang MM; Ang CW; Berkhout J; Bijlmer HA; Van Bortel W; Brandenburg AH; Van Burgel ND; Van Dam AP; Dessau RB; Fingerle V; Hovius JW; Jaulhac B; Meijer B; Van Pelt W; Schellekens JF; Spijker R; Stelma FF; Stanek G; Verduyn-Lunel F; Zeller H; Sprong H
    BMC Infect Dis; 2016 Mar; 16():140. PubMed ID: 27013465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Performance of Nine Commercial Serological Screening Assays for the Diagnosis of Lyme Borreliosis: a Multicenter Modified Two-Gate Design Study.
    Hoeve-Bakker BJA; Jonker M; Brandenburg AH; den Reijer PM; Stelma FF; van Dam AP; van Gorkom T; Kerkhof K; Thijsen SFT; Kremer K
    Microbiol Spectr; 2022 Apr; 10(2):e0051022. PubMed ID: 35297658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands.
    van Gorkom T; Sankatsing SUC; Voet W; Ismail DM; Muilwijk RH; Salomons M; Vlaminckx BJM; Bossink AWJ; Notermans DW; Bouwman JJM; Kremer K; Thijsen SFT
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of cellular tests for Lyme borreliosis (VICTORY) study.
    van de Schoor FR; Baarsma ME; Gauw SA; Joosten LAB; Kullberg BJ; van den Wijngaard CC; Hovius JW
    BMC Infect Dis; 2019 Aug; 19(1):732. PubMed ID: 31429716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of commercial screening tests and blot assays for the diagnosis of Lyme borreliosis.
    Busson L; Reynders M; Van den Wijngaert S; Dahma H; Decolvenaer M; Vasseur L; Vandenberg O
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):246-51. PubMed ID: 22560168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified interpretation criteria significantly improve performance of commercially available confirmatory assays for the serodiagnosis of Lyme borreliosis: a case-control study with clinically defined serum samples.
    Hauser U
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):529-539. PubMed ID: 30715667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lyme borreliosis--diagnostic difficulties in interpreting serological results].
    Gajović O; Todorović Z; Nesić L; Lazić Z
    Med Pregl; 2010; 63(11-12):839-43. PubMed ID: 21553464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of antibodies against B. burgdorferi, an indicator for Lyme borreliosis in dogs? A comparison of serological tests.
    Goossens HA; Maes JH; van den Bogaard AE
    Tijdschr Diergeneeskd; 2003 Nov; 128(21):650-7. PubMed ID: 14650723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.
    Magni R; Espina BH; Shah K; Lepene B; Mayuga C; Douglas TA; Espina V; Rucker S; Dunlap R; Petricoin EF; Kilavos MF; Poretz DM; Irwin GR; Shor SM; Liotta LA; Luchini A
    J Transl Med; 2015 Nov; 13():346. PubMed ID: 26537892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of serodiagnosis on the management of Lyme borreliosis at Angers University Hospital.
    Twizeyimana E; Pichard E; Lunel-Fabiani F; Fanello S; De Martino SJ
    Med Mal Infect; 2014 Sep; 44(9):429-32. PubMed ID: 25156778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feedback on difficulties raised by the interpretation of serological tests for the diagnosis of Lyme disease.
    Hansmann Y; Leyer C; Lefebvre N; Revest M; Rabaud C; Alfandari S; Christmann D; Tattevin P
    Med Mal Infect; 2014 May; 44(5):199-205. PubMed ID: 24794819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel lymphocyte transformation test (LTT-MELISA) for Lyme borreliosis.
    Valentine-Thon E; Ilsemann K; Sandkamp M
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):27-34. PubMed ID: 16876371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fifteen commercially available serological tests for diagnosis of Lyme borreliosis.
    Goossens HA; van den Bogaard AE; Nohlmans MK
    Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):551-60. PubMed ID: 10517192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular manifestations of Lyme borreliosis in northwest Croatia].
    Golubić D; Vinković T; Turk D; Hranilović J; Slugan I
    Lijec Vjesn; 2004; 126(5-6):124-8. PubMed ID: 15628679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory diagnosis and seroepidemiology of Lyme borreliosis.
    Stanek G
    Infection; 1991; 19(4):263-7. PubMed ID: 1917044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy between IDSA and ESGBOR in Lyme disease: Individual participant meta-analysis in Türkiye.
    Yıldız AB; Çetin E; Pınarlık F; Keske Ş; Can F; Ergönül Ö
    Zoonoses Public Health; 2024 Jun; 71(4):337-348. PubMed ID: 38413371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.